SunBird Bio

Merged

Cambridge, United States · Founded 2021 · $108.2M raised

Employees
11–50
Founded
2021
Business Model
B2B
Total Funding
$108.2M
Last Round
$85.0M Series BOct 2024
Rounds
2

About

SunBird Bio is a biotechnology company developing proprietary protein-based blood diagnostic tests to enable earlier and more accurate diagnosis and monitoring of Alzheimer's disease, Parkinson's disease, and other neurological disorders. The company's platform provides unprecedented protein-level insights from simple blood draws, supporting both clinical diagnosis and treatment monitoring.

Summary

SunBird Bio is a Biotech company based in Cambridge, United States, founded in 2021. It has raised $108.2M in total across 2 rounds, most recently a $85.0M Series B round in Oct 2024. Investors include Deerfield Management, Casdin Capital and ARCH Venture Partners.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BOct 2024
$85.0M

Sign up to see all 2 rounds

Series A through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

SunBird Bio on Indexed.vc
<a href="https://indexed.vc/companies/sunbird-bio"><img src="https://indexed.vc/api/badge/company/sunbird-bio" alt="SunBird Bio on Indexed.vc" width="260" height="76" /></a>